Low-molecular-weight organic uremic toxin precursors

Low-molecular-weight organic uremic toxin precursors are a group of small molecules, primarily indole, p-cresol, and phenol, generated by the metabolic activity of gut microbiota from dietary amino acids such as tryptophan and tyrosine (PMID: 21903988). In healthy individuals, these precursors are absorbed from the gastrointestinal lumen, transported to the liver, and metabolized into uremic toxins like indoxyl sulfate and p-cresyl sulfate, which are then excreted by the kidneys (PMID: 26912513). In patients with chronic kidney disease (CKD), impaired renal clearance leads to the systemic accumulation of these toxins, which contribute to uremic syndrome, oxidative stress, and accelerated cardiovascular damage (PMID: 22939138). Therapeutic strategies target these precursors within the gastrointestinal tract to prevent their entry into the circulation. For example, the oral adsorbent AST-120 (Kremezin) physically binds these precursors in the gut lumen, allowing them to be excreted in the feces and thereby reducing the systemic burden of uremic toxins in CKD patients (PMID: 19133024, PMID: 29334350).

Other names

Gut-derived uremic toxin precursorsMicrobiota-derived uremic precursorsIndole and p-cresolUremic toxin precursors

Gastrointestinal adsorption to prevent systemic absorption and subsequent hepatic conversion into uremic toxins.